Edward Lain

1.2k total citations
78 papers, 686 citations indexed

About

Edward Lain is a scholar working on Dermatology, Epidemiology and Oncology. According to data from OpenAlex, Edward Lain has authored 78 papers receiving a total of 686 indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Dermatology, 15 papers in Epidemiology and 12 papers in Oncology. Recurrent topics in Edward Lain's work include Acne and Rosacea Treatments and Effects (38 papers), Dermatology and Skin Diseases (20 papers) and Skin Protection and Aging (19 papers). Edward Lain is often cited by papers focused on Acne and Rosacea Treatments and Effects (38 papers), Dermatology and Skin Diseases (20 papers) and Skin Protection and Aging (19 papers). Edward Lain collaborates with scholars based in United States, Canada and Brazil. Edward Lain's co-authors include Julie Harper, Thomas Horn, Linda Stein Gold, Jerry Tan, Andrew Blauvelt, Abby Jacobson, Leon Kircik, Todd Schlesinger, Steven Kempers and Rajeev Chavda and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Journal of Investigative Dermatology.

In The Last Decade

Edward Lain

67 papers receiving 662 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward Lain United States 14 498 141 108 95 85 78 686
Moon Bum Kim South Korea 15 394 0.8× 185 1.3× 87 0.8× 66 0.7× 54 0.6× 57 732
D. Morgado‐Carrasco Spain 14 353 0.7× 105 0.7× 77 0.7× 49 0.5× 105 1.2× 139 625
Francesco Cusano Italy 16 586 1.2× 99 0.7× 143 1.3× 144 1.5× 120 1.4× 50 831
Steven Kempers United States 20 652 1.3× 262 1.9× 119 1.1× 200 2.1× 110 1.3× 49 1.0k
Hiram Larangeira de Almeida Brazil 13 273 0.5× 196 1.4× 123 1.1× 40 0.4× 62 0.7× 105 660
Margaret Song South Korea 15 336 0.7× 119 0.8× 59 0.5× 174 1.8× 31 0.4× 46 574
Jeong Deuk Lee South Korea 14 425 0.9× 139 1.0× 55 0.5× 29 0.3× 81 1.0× 63 687
Engin Sezer Türkiye 14 331 0.7× 137 1.0× 176 1.6× 90 0.9× 48 0.6× 57 561
Yasuyuki Sumikawa Japan 16 249 0.5× 82 0.6× 126 1.2× 174 1.8× 60 0.7× 36 658
Krešimir Kostović Croatia 15 316 0.6× 82 0.6× 87 0.8× 169 1.8× 35 0.4× 44 576

Countries citing papers authored by Edward Lain

Since Specialization
Citations

This map shows the geographic impact of Edward Lain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Lain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Lain more than expected).

Fields of papers citing papers by Edward Lain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Lain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Lain. The network helps show where Edward Lain may publish in the future.

Co-authorship network of co-authors of Edward Lain

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Lain. A scholar is included among the top collaborators of Edward Lain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Lain. Edward Lain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lebwohl, Mark, Edward Lain, Amy McMichael, Maryanne M. Senna, & Natasha Atanaskova Mesinkovska. (2025). Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors. SHILAP Revista de lepidopterología. 7. 1–8.
2.
Lain, Edward, Kenneth Beer, Joely Kaufman, et al.. (2025). 61656 READY-4: Long-term safety with repeated injections using RelabotulinumtoxinA, a novel liquid formulation botulinum toxin, in the treatment of glabellar and lateral canthal lines. Journal of the American Academy of Dermatology. 93(3). AB282–AB282. 1 indexed citations
4.
Lebwohl, Mark, April W. Armstrong, Andrew Alexis, Edward Lain, & Abby Jacobson. (2024). Efficacy of Brodalumab in Patients with Psoriasis and Risk Factors for Treatment Failure: A Review of Post Hoc Analyses. Dermatology and Therapy. 14(10). 2709–2726. 2 indexed citations
6.
Bhatia, Neal, Edward Lain, Abel Jarell, et al.. (2024). Safety and tolerability of tirbanibulin ointment 1% treatment on 100 cm2 of the face or scalp in patients with actinic keratosis: A phase 3 study. JAAD International. 17. 6–14. 5 indexed citations
7.
Kircik, Leon, Jerry Tan, Edward Lain, et al.. (2024). One Acne™: A holistic management approach to improve overall skin quality and treatment outcomes in acne with or without sensitive skin. International Journal of Dermatology. 64(4). 637–646.
9.
Sullivan, Kelly, Robert M. Law, Edward Lain, et al.. (2023). Evaluation of a retinol containing topical treatment to improve signs of neck aging. Journal of Cosmetic Dermatology. 22(10). 2755–2764.
10.
Eichenfield, Lawrence F., Mark Boguniewicz, Eric L. Simpson, et al.. (2023). ONCE-DAILY ROFLUMILAST CREAM 0.15% FOR ATOPIC DERMATITIS: POOLED Results: FROM INTEGUMENT-1/2 PHASE 3 TRIALS. Annals of Allergy Asthma & Immunology. 131(5). S91–S91. 4 indexed citations
11.
Eichenfield, Lawrence F., Linda Stein Gold, Leon Kircik, et al.. (2023). Triple‐combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel for moderate‐to‐severe acne in children and adolescents: Randomized phase 2 study. Pediatric Dermatology. 40(3). 452–459. 7 indexed citations
12.
Kircik, Leon, Neal Bhatia, Edward Lain, & Abby Jacobson. (2023). Breaking the Frustrating Cycle of Topical Steroids in Psoriasis: A Review of a Novel Vehicle for Fixed-Dose Combination Halobetasol Propionate/Tazarotene. Journal of Drugs in Dermatology. 22(3). 247–251. 1 indexed citations
13.
Rosso, J.Q. Del, et al.. (2022). Trifarotene 0.005% Cream in the Treatment of Facial and Truncal Acne Vulgaris in Patients with Skin of Color: a Case Series. Dermatology and Therapy. 12(9). 2189–2200. 3 indexed citations
14.
Baldwin, Hilary, Andrew Alexis, Anneke Andriessen, et al.. (2021). Evidence of Barrier Deficiency in Rosacea and the Importance of Integrating OTC Skincare Products into Treatment Regimens. Journal of Drugs in Dermatology. 20(4). 384–392. 11 indexed citations
15.
Tan, Jerry, Stefan Beissert, Fran Cook-Bolden, et al.. (2021). Evaluation of psychological well-being and social impact of atrophic acne scarring: A multinational, mixed-methods study. JAAD International. 6. 43–50. 19 indexed citations
16.
King, Brett, Catherine Maari, Edward Lain, et al.. (2021). Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical Trials. American Journal of Clinical Dermatology. 22(3). 395–405. 32 indexed citations
17.
Tan, Jerry, Stefan Beissert, Fran Cook-Bolden, et al.. (2021). Impact of Facial Atrophic Acne Scars on Quality of Life: A Multi-country Population-Based Survey. American Journal of Clinical Dermatology. 23(1). 115–123. 34 indexed citations
18.
Grada, Ayman, Martijn B. A. van Doorn, Edward Lain, Katharine Furst, & Gary Feiss. (2019). LB1092 Topical omiganan for severe papulopustular rosacea: A randomized, vehicle-controlled, double-blind, multicenter study. Journal of Investigative Dermatology. 139(9). B13–B13. 3 indexed citations
19.
Lain, Edward & Ramsey Markus. (2005). Early and explosive development of nodular basal cell carcinoma and multiple keratoacanthomas in psoriasis patients treated with cyclosporine.. PubMed. 3(6). 680–2. 15 indexed citations
20.
Lain, Edward. (2005). Imiquimod Treatment of Exuberant Granulation Tissue in a Nonhealing Diabetic Ulcer. Archives of Dermatology. 141(11). 1368–1368. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026